Report: 2025 Pharmaceutical Packaging Market Prospects
The 2025 Pharma Packaging Market Prospects report details the leading trends and demands in pharmaceutical packaging, and the challenges that continue to drive innovation in safe, affordable, and sustainable packaging solutions. In this report, we explore the blockbuster drugs demanding new forms of packaging, the sustainability concerns and regulations driving the packaging sector, and regional policies and shifting priorities for the pharmaceutical supply chain as a whole. With expert contributors from the likes of L.E.K. Consulting, allpack group, and West Pharmaceutical Services, we look at how the pharmaceutical packaging sector more involved than ever in lifechanging decisions within the pharmaceutical industry and supply chain.
News: Year in Review: The 10 most-read pharma articles of 2025
We feature the most popular articles published on CPHI Online from 2025, ranging from blockbuster news over GLP-1 therapies, including discussions with experts on the subject, to some of our regular interview series features, and content surrounding our biggest event of the year, CPHI Frankfurt.
Brochure: Sustainability in Pharma - Infographic
CPHI spoke with pharma supply chain leaders to dive into the industry’s current status, challenges, and strategies when it comes to sustainability. Our experts comment on: what sustainability means to them what are the main sustainability challenges they face how they are actively working towards a more sustainable future The infographic also shows how we, at CPHI, are striving for a more sustainable future: running our events in as sustainable manner as possible encouraging sustainable ideas being conscious of the materials we use providing educational content on sustainability Download our free infographic to get the inside scoop on all things sustainability, direct from the expert’s leading our industry!
News: Reckoning with a new pharma landscape: the CPHI Americas Roundtable Round-Up
As part of our CPHI Americas conference sessions, we held a closed roundtable bringing together top pharmaceutical industry experts and thought leaders to discuss the most pertinent issues and trends surrounding the whole of the American pharmaceutical value chain. Our discussion spanned such topics as AI and its regulatory landscape in pharma, outsourcing trends and challenges, and the market potential of Latin America, diving deep into a stimulating exchange of ideas and perspectives.
Report: Sustainability Report 2024: a Guide to Growing a Greener Industry
The pharmaceutical industry is well aware of the impacts of climate change on human health, and increasingly aware of the impact the industry has in contributing to this. Connecting these dots, leaders in the field see how planet health is intrinsically linked to human health, and therefore, must be addressed as part of the mission of the healthcare industry. At CPHI, we’ve looked into the aspects of the pharmaceutical value chain that contribute to green house gas emissions, as well as the effects of waste. Now, the Sustainability Report 2024, a guide to growing a greener industry, takes these lessons to the next step and proposes how exactly pharmaceutical specialists can help to reduce climate change and preserve life. With input from experts from The PSCI, BioPhorum, Nelipak Healthcare Packaging, Pöppelmann FAMAC Pharma-Medical, Anthesis Consulting Group, Pantheon Strategies, Schneider Electric, and Singota Solutions, the report covers key challenges and solutions for all players, including valuable case studies, and information on legislation, investing, and materiality. The report covers: Chapter one: What did we learn from 2023 and where are we now? Chapter two: Wrangling with regulation Chapter three: Investing in sustainability Chapter four: What can emerging markets bring to the sustainability table? Chapter five: We’re all living in a material world Chapter six: Collaborative action through partnerships Chapter seven: At the heart of sustainable pharma We also hear from CPHI itself about the approach to making events more environmentally conscious and the role they can play in bringing sustainability conversations to the fore.
Report: The 2024 Pharma Outsourcing Forecast: strategic partnerships across global landscapes
Pharmaceutical outsourcing strategies have evolved to match the dynamic needs of drugmakers and biotechs. As more and more pharmaceutical companies outsource some percentage of their operations, the partnerships between contracted organisations and drug sponsors are shifting in response to changing priorities from both parties. The future of pharmaceutical outsourcing is constantly changing, and success will depend on the pharma industry’s ability to adapt and evolve to meet these challenges.
News: CPHI Online Trend Report – 2025 Pharma Packaging Prospects
The pharmaceutical packaging market has seen marked shifts in innovations, priorities, and focus over the last few years. With the rise of hit drugs like GLP-1 agonists and biologics requiring specialised packaging considerations, the strain of meeting sustainability and patient-centric goals, all while balancing costs, time, and efficiency, the pharmaceutical packaging sector is gearing up for valuable opportunities to capitalise on in the market.
Report: Pharmaceutical Packaging Report: True Cost of Pharma Packaging
The pharmaceutical packaging sector has seen an increased amount of interest in the last few years. With record numbers of attendees, exhibitors, and speakers at this year’s Pharmapack 2024, and several upcoming regulatory changes regarding packaging across all industries, it is clear that packaging innovation for the pharma industry is and will continue to be a priority. For the pharma industry and supply chain, there are many factors to consider when it comes to packaging. One of the top priorities is sustainability, both through operations and materials. The health of the planet is intrinsically linked to human health and must be addressed as part of every business decision in pharmaceutical packaging. However, as with all pharmaceutical products, packaging experts must also consider patient safety, drug efficacy, and the ultimate cost of the above. In our latest Trend Report, we uncover what it’s truly costing pharmaceutical packagers to consider the Triple Bottom Line of People, Planet, and Profit. With expert insight from the CiPPPA, Takeda Pharmaceuticals, the European Co-Packers Association, and more, this report explores how the pharmaceutical industry can balance the health of their business with the health of the people and planet.
Report: CPHI Annual Report 2024
The CPHI Annual Report 2024 once again highlights the challenges and opportunities de jour in global pharma, looking ahead to provide vital early insights on the trends and developments that will shape the industry over the next 5-years. The first section provides a review of the Annual CPHI Survey followed by analysis from 10+ global experts who forecast the trends of tomorrow.
News: Pharmapack 2025: From the Floor in Paris
Pharmpack gears up for another week in Paris at the Porte De Versailles. The two-day show taking place on the 22–23 January, will cover contract packaging, device innovation, and sustainability among other topics.
Report: CPHI Milan Wrap-Up Report: Key Insights from the Heart of Pharma
Celebrating its 35th edition, CPHI Milan was held 8–10 October, 2024 at the historic Fiera Milano exhibition centre. Bringing together over 60,000 attendees worldwide, 2,400 exhibiting companies, and 150 international expert speakers, CPHI Milan connected the global pharmaceutical supply chain for 3 days of innovation and thought leadership. CPHI Online are proud to bring you the first edition of the CPHI Wrap-Up Report, featuring key insights from CPHI Milan and the wider pharmaceutical industry. Exclusive content from the show floor, conference theatres, and exhibiting hubs showcase the power of inperson connection and collaboration. This report also features exclusive interviews with expert speakers from such companies as Polpharma, Daiichi Sankyo, Moderna, the European Commission, Novartis, and many more. Whether you’re looking to relive the CPHI experience, or catch up on all the buzz you missed at the event, this report is your exclusive ticket to all key findings at CPHI Milan.
Report: Trend Report - The True Cost of API Price Rises
As a direct result of various environmental and socio-political events in the last 2 years, the pharmaceutical industry is gra
